Boundless Bio Inc (BOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2018 | 12-2017 | |
| Operating Expenses | 73,267 | 54,796 | 46,469 | 134,372 | 93,177 |
| Operating Income | -73,267 | -54,796 | -46,469 | -134,372 | -93,177 |
| Other Income | 7,904 | 5,362 | 568 | 5,551 | 693 |
| Pre-tax Income | -65,363 | -49,434 | -45,901 | -128,821 | -92,484 |
| Income Tax | N/A | N/A | N/A | N/A | -2,246 |
| Net Income Continuous | -65,363 | -49,434 | -45,901 | -128,821 | -90,238 |
| Net Income | $-65,363 | $-49,434 | $-45,901 | $-128,821 | $-90,238 |
| EPS Basic Total Ops | -3.85 | -40.65 | -41.80 | -3.40 | -3.40 |
| EPS Basic Continuous Ops | -3.85 | -40.65 | -41.80 | -3.40 | -3.40 |
| EPS Diluted Total Ops | -3.85 | -40.65 | -41.80 | -3.40 | -3.40 |
| EPS Diluted Continuous Ops | -3.85 | -40.65 | -41.80 | -3.40 | -3.40 |
| EPS Diluted Before Non-Recurring Items | -3.85 | N/A | N/A | -3.40 | -3.40 |
| EBITDA(a) | $-72,181 | $-53,839 | $-45,527 | $-130,588 | $-90,095 |